Clicky

China Medical System Holdings Ltd(0867)

Description: China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar. Its products also comprise DanShenTong capsules for treating acne, tonsillitis, otitis externa, boils, carbuncle, traumatic infection, burn infection, mastitis, cellulitis, osteomyelitis, etc.; XiDaKang, a protein hydrolysate oral solution; YiNuoShu for treating respiratory diseases; Ganfule capsules for the treatment of primary cancer of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; and Parlodel tablets for the endocrine and neuro system indications. In addition, the company also offers Elcatonin injection for osteoporosis; YinlianQinggan granules for treating acute hepatitis A and chronic hepatitis B; Lamisil tablets for treating fungal infections on skin and hair; and MOVICOL for treating chronic constipation and faecal impaction. In addition, it is involved in the agriculture and livestock activities. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.


Keywords: Medicine Pharmaceutical Products Infectious Diseases Infection Hypertension Hepatitis Osteoporosis Liver Disease Respiratory Diseases Ulcerative Colitis Acne Crohn's Disease Diarrhea Chronic Condition Acute Pain Angina Coronary Artery Disease Myocardial Infarction Treatment Of Hypertension Vaccine Preventable Diseases Chronic Hepatitis B Chronic Heart Failure Fungal Infections Coronary Heart Disease Acute Heart Failure Chronic Constipation Mastitis Asthenopia Carbuncle Cellulitis Lamisil Tonsillitis Treatment Of Acute Heart Failure Treatment Of Diarrhea Acute Hepatitis A Biliary Reflux Gastritis Boils Cholestatic Liver Disease Cholesterol Gallstones Mixed Angina Osteomyelitis Otitis Externa Parlodel Protein Hydrolysate Oral Solution Salofalk Stable Angina Pectoris Superficial Phlebitis Traumatic Infection Treatment Of Coronary Heart Disease Ursofalk

Home Page: www.cms.net.cn

Island Place Tower
North Point,
Hong Kong
Phone: 852 2369 7678


Officers

Name Title
Mr. Kong Lam Founder, Chairman, CEO & Pres
Ms. Yanling Chen CFO, VP & Exec. Director
Mr. Hongbing Chen COO, VP, Director of Sales & Marketing and Exec. Director
Dr. Wai Ming Wong Chief Technical Officer
Ms. Sanyan Wu Director of Legal Department & Company Sec.

Exchange: HK

Country: HK : Hong Kong

Currency: Hong Kong Dollar (HK$)

Forward PE: 8.8496
Trailing PE: 9.12
Price-to-Book MRQ: 2.0942
Price-to-Sales TTM: 3.3783
IPO Date: 2007-06-26
Fiscal Year End: December
Full Time Employees: 5454
Back to stocks